Advertisement
Screener

PTC Therapeutics, Inc. (PTCT) Graph

PTCT Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $360.52M; Revenue including tax (m); Cost of revenue (m); Research and development $99.15M.
  • 2026-03-31: Revenue $272.55M; Revenue including tax (m); Cost of revenue (m); Research and development $100.87M.
  • 2025-12-31: Revenue $164.68M*; Revenue including tax (m); Cost of revenue (m); Research and development $133.13M*.
  • 2025-09-30: Revenue $211.01M; Revenue including tax (m); Cost of revenue (m); Research and development $100.16M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PTCT revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Product$238.82MRoyalty$71.10MCollaboration AndLicense Revenue$50.60MEmflaza$24.63MOther Products$9.50MSephience$151.31MTranslarna$42.22MUpstaza And Kebilidi$11.16MRevenue$360.52MOperating expenses$211.54MOperating income$148.98MOther income, net-$2.95MResearch & development$99.15MSelling, general& administrative$80.63MPre-tax income$97.54MIncome tax$14.05MNet income$83.50M

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PTCT revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.All Other Countries Other ThanRussia Brazil And United States$52.84MBR$25.58MRU$8.21MUS$152.18MRevenue$360.52MOperating expenses$211.54MOperating income$148.98MOther income, net-$2.95MResearch & development$99.15MSelling, general& administrative$80.63MPre-tax income$97.54MIncome tax$14.05MNet income$83.50M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$360.52M(m)(m)$99.15M$80.63M$211.54M$14.05M$83.50M
2026-03-31$272.55M(m)(m)$100.87M$86.18M$227.59M$347.00K-$2.81M
2025-12-31$164.68M*(m)(m)$133.13M*$96.87M*$236.03M*-$4.12M*-$134.61M*
2025-09-30$211.01M(m)(m)$100.16M$84.05M$207.99M-$38.97M$15.90M
2025-06-30$178.88M(m)(m)$112.99M$85.26M$213.83M-$6.20M-$64.85M
2025-03-31$1.18B(m)(m)$108.97M$80.96M$205.87M$63.27M$866.56M
2024-09-30$196.79M(m)(m)$161.41M$73.46M$251.30M$8.66M-$106.65M
2024-06-30$186.70M(m)(m)$132.17M$69.50M$226.92M$13.45M-$99.18M
2024-03-31$210.12M(m)(m)$116.13M$73.27M$255.57M$6.88M-$91.58M
2023-09-30$196.58M(m)(m)$164.21M$80.89M$314.74M-$33.62M-$132.97M
2023-06-30$213.81M(m)(m)$185.87M$88.45M$423.35M-$38.60M-$198.88M
2023-03-31$220.38M(m)(m)$195.12M$86.91M$338.00M$3.97M-$138.96M
2022-09-30$217.13M(m)(m)$165.46M$80.12M$285.31M-$17.89M-$109.31M
2022-06-30$165.53M(m)(m)$157.26M$79.89M$257.89M$3.39M-$152.09M
2022-03-31$148.74M(m)(m)$140.08M$73.27M$235.26M$4.83M-$126.73M
2021-09-30$138.74M(m)(m)$130.84M$69.25M$231.82M-$36.00K-$133.62M
2021-06-30$116.68M(m)(m)$125.48M$68.88M$215.17M$488.00K-$118.37M
2021-03-31$117.94M(m)(m)$134.51M$61.09M$216.09M$451.00K-$128.64M
2020-12-31(m)(m)(m)(m)(m)$215.24M(m)-$74.35M
2020-09-30$118.40M(m)(m)$93.00M$57.84M$173.53M$22.29M-$69.69M
2020-06-30$75.24M$75.24M(m)$176.53M$53.66M$262.51M$84.00K-$181.43M
2020-03-31$68.26M$68.26M(m)$90.11M$58.21M$161.25M$222.00K-$112.69M
2019-12-31(m)$96.46M*$3.54M*(m)(m)$169.24M(m)-$77.68M
2019-09-30$71.42M$71.42M$3.01M$63.08M$49.28M$131.89M-$344.00K-$60.00M
2019-06-30(m)$85.52M$3.21M$59.98M$49.22M$124.28M$774.00K-$41.79M
2019-03-31(m)$53.58M$2.38M$52.57M$40.54M$122.72M$576.00K-$72.11M
2018-12-31(m)$85.83M(m)(m)(m)$131.48M(m)-$48.33M
2018-09-30(m)$53.59M$3.29M$54.37M$38.37M$101.82M$355.00K-$50.97M
2018-06-30(m)$68.74M$2.57M$32.61M$33.55M$74.32M$389.00K-$9.52M
2018-03-31$56.06M$56.06M$3.04M$31.36M$32.97M$72.81M$221.00K-$19.26M
2017-12-31(m)$57.95M(m)(m)(m)$72.58M(m)$1.27M
2017-09-30$41.85M$41.78M$1.58M$30.02M$31.42M$72.75M$191.00K-$33.74M
2017-06-30$47.96M$47.89M$758.00K$30.84M$28.87M$60.46M$150.00K-$17.48M
2017-03-31$26.55M$26.44M(m)$27.36M$25.50M$52.90M$165.00K-$29.06M
2016-12-31(m)(m)(m)(m)(m)$50.18M(m)-$26.80M
2016-09-30$22.99M(m)(m)$31.40M$23.65M$55.05M$184.00K-$35.17M
2016-06-30$15.63M(m)(m)$28.83M$23.37M$52.19M-$93.00K-$38.91M
2016-03-31$18.89M(m)(m)$31.40M$25.94M$57.34M$114.00K-$41.23M
2015-12-31(m)(m)(m)(m)(m)$60.94M(m)-$50.95M
2015-09-30$9.78M(m)(m)$30.64M$21.37M$52.01M$88.00K-$43.22M
2015-06-30$6.77M(m)(m)$28.19M$17.21M$45.40M$145.00K-$38.36M
2015-03-31$7.48M(m)(m)$27.94M(m)$45.55M(m)-$37.91M
2014-12-31(m)(m)(m)(m)(m)$44.89M(m)-$27.27M
2014-09-30$1.69M(m)(m)$18.77M(m)$29.30M(m)-$27.28M
2014-06-30$1.68M(m)(m)$18.31M(m)$27.05M(m)-$25.10M
2014-03-31$9.22M(m)(m)$15.89M(m)$23.43M(m)-$14.10M
2013-12-31$4.41M(m)(m)(m)(m)$22.50M(m)-$17.89M
2013-09-30$16.29M(m)(m)$13.89M(m)$20.57M(m)-$4.42M
2013-06-30$6.85M(m)(m)$14.71M(m)$21.31M(m)-$14.59M
2013-03-31$7.14M(m)(m)$11.26M(m)$15.72M(m)-$14.69M
2012-12-31$6.64M(m)(m)(m)(m)$12.67M(m)-$6.27M
2012-09-30$7.20M(m)(m)$10.47M(m)$14.25M(m)-$7.30M
2012-06-30$7.59M(m)(m)$11.92M(m)$15.08M(m)-$6.07M
2012-03-31$12.53M(m)(m)(m)(m)$18.75M(m)-$6.60M

Revenue and expense 6 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$633.07M(m)(m)$200.02M$166.81M$439.13M$14.40M$80.69M
2025-06-30$1.35B(m)(m)$221.96M$166.22M$419.70M$57.06M$801.71M
2024-06-30$396.82M(m)(m)$248.30M$142.77M$482.49M$20.33M-$190.75M
2023-06-30$434.19M(m)(m)$381.00M$175.36M$761.35M-$34.63M-$337.84M
2022-06-30$314.26M(m)(m)$297.34M$153.16M$493.14M$8.23M-$278.81M
2021-06-30$234.62M(m)(m)$260.00M$129.97M$431.26M$940.00K-$247.01M
2020-06-30$143.50M$143.50M(m)$266.63M$111.87M$423.76M$306.00K-$294.11M
2019-06-30(m)$139.10M$5.59M$112.54M$89.76M$247.00M$1.35M-$113.90M
2018-06-30(m)$124.81M$5.62M$63.97M$66.51M$147.12M$610.00K-$28.78M
2017-06-30$74.51M$74.51M$797.00K$58.20M$54.37M$113.36M$316.00K-$46.53M
2016-06-30$34.53M(m)(m)$60.23M$49.30M$109.53M$22.00K-$80.15M
2015-06-30$14.26M(m)(m)$56.13M$34.83M$90.95M$145.00K-$76.28M
2014-06-30$10.89M(m)(m)$34.20M(m)$50.48M(m)-$39.20M
2013-06-30$14.00M(m)(m)$25.97M(m)$37.02M(m)-$29.27M
2012-06-30$20.11M(m)(m)$26.22M(m)$33.83M(m)-$12.67M

Revenue and expense 9 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$1.57B(m)(m)$322.12M$250.27M$627.69M$18.09M$817.61M
2024-09-30$593.61M(m)(m)$409.71M$216.23M$733.79M$28.99M-$297.41M
2023-09-30$630.77M(m)(m)$545.21M$256.25M$1.08B-$68.25M-$470.81M
2022-09-30$531.39M(m)(m)$462.80M$233.28M$778.46M-$9.67M-$388.13M
2021-09-30$373.36M(m)(m)$390.84M$199.22M$663.08M$904.00K-$380.64M
2020-09-30$261.90M(m)(m)$359.63M$169.71M$597.30M$22.59M-$363.81M
2019-09-30$210.52M$210.52M$8.59M$175.62M$139.04M$378.89M$1.01M-$173.90M
2018-09-30(m)$178.40M$8.91M$118.34M$104.88M$248.94M$964.00K-$79.75M
2017-09-30$116.36M$116.36M$2.14M$88.22M$85.79M$186.10M$507.00K-$80.27M
2016-09-30$57.51M(m)(m)$91.62M$72.96M$164.58M$206.00K-$115.31M
2015-09-30$24.03M(m)(m)$86.77M$56.19M$142.96M$233.00K-$119.50M
2014-09-30$12.59M(m)(m)$52.97M(m)$79.77M(m)-$66.48M
2013-09-30$30.29M(m)(m)$39.85M(m)$57.59M(m)-$33.69M
2012-09-30$27.31M(m)(m)$36.69M(m)$48.08M(m)-$19.96M

Revenue and expense 12 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$1.73B(m)(m)$455.25M$347.14M$863.72M$13.97M$683.00M
2024-12-31$806.78M(m)(m)$534.48M$300.91M$1.11B$176.00K-$363.30M
2023-12-31$937.82M(m)(m)$666.56M$332.54M$1.38B-$69.51M-$626.60M
2022-12-31$698.80M(m)(m)$651.50M$326.00M$1.15B-$28.47M-$559.00M
2021-12-31$538.59M(m)(m)$540.68M$285.77M$913.04M$5.56M-$523.90M
2020-12-31$380.77M(m)(m)$477.64M$245.16M$812.53M$35.23M-$438.16M
2019-12-31$306.98M$306.98M$12.13M$257.45M$202.54M$548.14M$11.65M-$251.58M
2018-12-31$264.73M$264.73M$12.67M$171.98M$153.55M$380.42M-$29.00K-$128.08M
2017-12-31$194.39M$194.39M$4.58M$117.46M$121.27M$258.68M$1.33M-$79.00M
2016-12-31$82.70M$82.70M(m)$117.63M$97.13M$214.76M$569.00K-$142.11M
2015-12-31$36.77M(m)(m)$121.82M(m)$203.90M$485.00K-$170.45M
2014-12-31$25.25M(m)(m)$79.84M(m)$124.66M-$4.69M-$93.75M
2013-12-31$34.70M(m)(m)$54.88M(m)$80.09M(m)-$51.57M
2012-12-31$33.95M(m)(m)$46.14M(m)$60.75M(m)-$26.23M
2011-12-31$105.41M(m)(m)$58.68M(m)$74.83M-$2.31M$30.90M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dianthus Therapeutics, Inc. /DE/ (DNTH)United States$5.082B-27.79
Erasca, Inc. (ERAS)United States$5.073B-19.96
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
Veradermics, Inc (MANE)United States$4.839B
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Edgewise Therapeutics, Inc. (EWTX)United States$4.470B-22.23
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51